Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Protein and Peptide Letters|July 25, 2016
Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaKDaniel Knappe, Tina Goldbach, Marcus P D Hatfield, et al.Protein and Peptide Letters|October 30, 2013
Blood-brain barrier transport of short proline-rich antimicrobial peptidesSofie Stalmans, Evelien Wynendaele, Nathalie Bracke, et al.Amino Acids|September 4, 2015
Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureusDaniel Knappe, Serge Ruden, Stefanie Langanke, et al.Frontiers in Microbiology|January 23, 2024
Evaluation of proline-rich antimicrobial peptides as potential lead structures for novel antimycotics against <i>Cryptococcus neoformans</i>Alexandra Brakel, Thomas Grochow, Stefanie Fritsche, et al.Journal of Global Antimicrobial Resistance|December 29, 2020
Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strainAnn-Kathrin Krieger, Daniel Knappe, Sophie Öhlmann, et al.Biopolymers|February 17, 2015
Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signalingLaszlo Otvos, Ilona Kovalszky, Julia Olah, et al.Molecular Pharmaceutics|May 4, 2022
Simultaneous Chromatographic Quantitation of Drug Substance and Excipients in Nanoformulations Using a Combination of Evaporative Light Scattering and Absorbance DetectorsRoland Böttger, Po-Han Chao, Nojoud Al Fayez, et al.The Journal of Antimicrobial Chemotherapy|September 3, 2010
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infectionsEszter Ostorhazi, Ferenc Rozgonyi, Andras Sztodola, et al.Amino Acids|December 25, 2013
The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptorLaszlo Otvos, Stefan W Vetter, Mohit Koladia, et al.BMC Biotechnology|October 7, 2011
Design and development of a peptide-based adiponectin receptor agonist for cancer treatmentLaszlo Otvos, Eva Haspinger, Francesca La Russa, et al.Pageof 6